Search for Clinical Trial Results

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma - 25 Studies Found
Status | Study |
Completed |
Study Name: 506U78 In Relapsed Or Refractory Acute Lymphoblastic Leukemia (T-ALL) Condition: T-ALL, T-NHL (Lymphoblastic) Date: 2008-05-16 Interventions: Drug: Nelarabine 1500 mg/m² i.v., duration 2 hrs, day 1, 3, 5 |
Completed |
Study Name: Hyper-CVAD Treatment of Adult T-cell Acute Lymphoblastic Leukemia in Sweden. Condition: T-cell Acute Lymphoblastic Leukemia Date: 2013-09-07 |
Recruiting |
Study Name: A Study of LY3039478 in Combination With Dexamethasone in Participants With T-ALL/T-LBL Condition:
|
Terminated |
Study Name: Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL Condition:
|
Active, not recruiting |
Study Name: Evaluation and Treatment of Tall Statured Girls Condition: Constitutional Tall Stature Date: 2015-12-13 Interventions: Drug: Estradiol Estradiol containing compounds administered orally in a non-randomized manner. |
Recruiting |
Study Name: BL-8040 and Nelarabine for Relapsed or Refractory T-Acute Lymphoblastic Leukemia/ Lymphoblastic Lymphoma Condition:
|
Active, not recruiting |
Study Name: Study to Evaluate the Safety and Tolerability of Weekly Intravenous (IV) Doses of BMS-906024 in Subjects With Acute T-cell Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma Condition:
|
Recruiting |
Study Name: Safety and Efficacy of Isatuximab in Lymphoblastic Leukemia Condition: T-cell Type Acute Leukemia-Precursor T-lymphoblastic Lymphoma/Leukaemia Date: 2016-12-19 Interventions:
|
Recruiting |
Study Name: Combination Chemotherapy With or Without Bortezomib in Treating Younger Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Stage II-IV T-Cell Lymphoblastic Lymphoma Condition:
|
Active, not recruiting |
Study Name: Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma Condition:
|